Related Experiment Videos

EBR-1, a novel Ambler subclass B1 beta-lactamase from Empedobacter brevis

Samuel Bellais1, Delphine Girlich, Amal Karim

  • 1Service de Bactériologie-Virologie, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine Paris-Sud, 94275 Le Kremlin-Bicêtre Cédex, France.

Summary

Empedobacter brevis produces a novel class B beta-lactamase, EBR-1, conferring resistance to carbapenems and cephalosporins. This metalloenzyme shows potential for widespread clinical resistance in gram-negative infections.

Related Concept Videos